LivaNova (LIVN) EBT Margin Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -305.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -9.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -222.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 923.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -480.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,114.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,391.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -176.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 329.00 |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn | 388.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 388.00 |
| Dec 31, 2025 | 533.00 |
| Sep 30, 2025 | 5,148.00 |
| Jun 30, 2025 | 198.00 |
| Mar 31, 2025 | -10,194.00 |
| Dec 31, 2024 | 1,840.00 |
| Sep 30, 2024 | 3,038.00 |
| Jun 30, 2024 | 2,664.00 |
| Mar 31, 2024 | -26.00 |
| Dec 31, 2023 | 8,150.00 |
| Sep 30, 2023 | 710.00 |
| Jun 30, 2023 | 1,369.00 |
| Mar 31, 2023 | 619.00 |
| Dec 31, 2022 | 5,547.00 |
| Sep 30, 2022 | -5,000.00 |
| Jun 30, 2022 | 2,030.00 |
| Mar 31, 2022 | 1,088.00 |
| Dec 31, 2021 | 9,321.00 |
| Sep 30, 2021 | -1,313.00 |
| Jun 30, 2021 | -2,639.00 |
| Mar 31, 2021 | -2,016.00 |
| Dec 31, 2020 | -11,474.00 |
| Sep 30, 2020 | -1,947.00 |
| Jun 30, 2020 | -3,653.00 |
| Mar 31, 2020 | -1,168.00 |
| Dec 31, 2019 | -6,211.00 |
| Sep 30, 2019 | -94.00 |
| Jun 30, 2019 | -2,114.00 |
| Mar 31, 2019 | 872.00 |